2007
DOI: 10.1007/s10198-007-0042-9 View full text |Buy / Rent full text
|
|

Abstract: Recent evidence has investigated the cost-effectiveness of magnetic resonance imaging (MRI) in younger women with a BRCA1 mutation. However, this evidence has not been contrasted with existing cost-effectiveness standards to determine whether screening is appropriate, given limited societal resources. We constructed a Markov model investigating surveillance tools (mammography, MRI, both in parallel) under a National Health Service (NHS) perspective. The key benefit of MRI is that increased sensitivity leads to… Show more

Help me understand this report

Search citation statements

Order By: Relevance
0
0
0
0
0
0
36
0

Publication Types

Select...

Relationship

0
0

Authors

Journals